A chitosan-based molecularly imprinted hydrogel technology designed to selectively bind and remove specific organic compounds from coconut water, enabling flavor profile refinement without altering its major composition. Leverages expertise in biopolymer engineering and molecular imprinting for food and beverage applications.
This solution offers a novel approach to enhancing the flavor profile of coconut water through a biopolymer-assisted adsorption process. The technology uses a chitosan-based molecularly imprinted hydrogel engineered to selectively bind specific target organic compounds identified in mature coconut flavor, such as aldehydes, lactones, and benzothiazoles. By selectively adsorbing these compounds, the technology aims to refine and improve coconut water flavor in a controlled manner without altering its fundamental composition. This presents an opportunity for beverage manufacturers and food processors seeking to optimize sensory characteristics of plant-based drinks.
Core technology:
Key features:
Validation evidence:
The underlying molecular imprinting approach has been previously validated using o-xylene as a model organic compound, demonstrating that molecularly imprinted chitosan hydrogels exhibit greater adsorption capacity than non-imprinted control matrices.
The technology is currently at laboratory proof-of-concept stage (TRL 3-4). Future validation work will include optimization of key parameters at laboratory scale: preparation of molecularly imprinted matrices against known coconut water flavor compounds, removal of targets by washing followed by freeze-drying, rebinding and selectivity studies with model pure compounds, and a proof-of-concept demonstration with actual coconut water. The research team at the University of Leeds has established expertise in engineering chitosan and other biopolymer-based materials, providing a strong foundation for advancing this technology toward commercial readiness.
The University of Leeds is a comprehensive, research‑intensive public university serving a large student body and global partner network. Industry partners engage through an on‑campus innovation hub offering flexible workspace, shared labs and prototyping, and options to co‑locate with academic experts. The university’s integration with major NHS teaching hospitals in the city enables clinical research, validation, and translation. Research is backed by competitive funding from UK Research and Innovation (UKRI) councils and the National Institute for Health and Care Research, with additional European and industry support. A dedicated technology transfer office manages IP, licensing, and spinouts, with partnership models and professional education tailored for corporate R&D.